Canadian Public Cannabis Companies Market Overview (Nov 2017)
Summary
The passage provides routine financial statistics on publicly traded cannabis firms in Canada with no indication of wrongdoing, influential actors, or novel controversy. It lacks actionable leads, spe As of Nov 30, 2017, 6 firms on TSX, 20 on TSXV, 41 on CSE. Combined enterprise value of Canadian cannabis firms was $210.6 billion. Stock performance boosted by Trudeau's recreational cannabis announ
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Ackrell Capital Cannabis OTC Market Valuation Table (2017)
The document is a financial listing of small OTC cannabis companies with market metrics. It contains no references to influential political figures, government agencies, or alleged misconduct, offerin Provides EV multiples and stock price discounts for over 40 cannabis firms. Compiled by Ackrell Capital, a FINRA/SIPC member. Data dated November 30, 2017.
Ackrell Capital Cannabis Investment Report shows rapid stock price gains and capital raises in Canadian cannabis sector (Dec 2017)
The document is a market performance summary with no specific allegations, names of wrongdoing, or actionable leads linking powerful actors to misconduct. It merely reports stock price movements and c Canadian cannabis stocks experienced massive price increases in 2017. Capital raised by publicly traded Canadian cannabis companies is quantified for the 12‑month period The report is produced by Ac
Ackrell Capital report shows modest capital raised by U.S. publicly traded cannabis companies in 2017
The passage provides only aggregate financial data on small, largely unprofitable cannabis firms with no mention of high‑profile individuals, government agencies, or illicit activity. It lacks specifi Only $268 million total equity and debt raised by listed cannabis firms in the 12‑month period endin Most companies had little to no revenue and were not profitable. A single large $317 million finan
Ackrell Capital Cannabis Company Financial Metrics Table
The document is a plain financial summary of cannabis companies listed on the Canadian Securities Exchange with no mention of influential actors, misconduct, or controversial transactions. It offers n Provides market cap, revenue, EBITDA, and valuation multiples for dozens of cannabis firms. Includes percentages of stock price below enterprise value. No names of political figures, government agenc
Cannabis Company Valuation Table from Cowen Report (Feb 2019)
The passage is a plain financial data table listing market metrics for cannabis companies. It contains no references to high‑profile individuals, government actions, or alleged misconduct, offering no Provides enterprise values, revenues, and price metrics for dozens of cannabis firms. Cites Thomson Reuters and Cowen as sources. Dated February 25, 2019, with no contextual commentary.
Market Overview of Publicly Traded Cannabis Companies Across U.S., Canadian, and Australian Exchanges
The passage provides aggregate financial data on cannabis‑related publicly traded firms and outlines exchange listing requirements. It contains no specific allegations, names, transactions, or links t Most cannabis companies trade on OTC in the U.S. due to lax regulations. Canadian exchanges (TSX, TSXV, CSE) have varying listing standards. CSE permits U.S. cannabis operations, unlike TSX/TSXV.
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.